A61K 39/125
Picornaviridae
Official title: Picornaviridae, e.g. calicivirus
A61K39/125 (Picornaviridae) appears on 272 US grants and 422 published applications in this corpus.
Search patents in A61K- Granted patents
- 272
- Published applications
- 422
- Assignees
- 245
- Inventors
- 949
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 5 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 1 |
| 2002 | 1 | 5 |
| 2003 | 1 | 7 |
| 2004 | 5 | 9 |
| 2005 | 1 | 9 |
| 2006 | 3 | 8 |
| 2007 | 6 | 5 |
| 2008 | 3 | 12 |
| 2009 | 5 | 6 |
| 2010 | 4 | 19 |
| 2011 | 5 | 16 |
| 2012 | 3 | 20 |
| 2013 | 9 | 22 |
| 2014 | 11 | 27 |
| 2015 | 10 | 22 |
| 2016 | 17 | 22 |
| 2017 | 14 | 15 |
| 2018 | 27 | 25 |
| 2019 | 25 | 30 |
| 2020 | 16 | 19 |
| 2021 | 19 | 28 |
| 2022 | 10 | 18 |
| 2023 | 11 | 19 |
| 2024 | 11 | 24 |
| 2025 | 7 | 19 |
| 2026 | 8 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Immune adjuvant and vaccine composition including the same29 Sep 2026US 12,746,284 B2Republic of Korea (Animal and Plant Quarantine Agency)
- Compositions and methods for preventing and treating virus infection15 Sep 2026US 12,734,234 B2University of Virginia Patent Foundation
- Inactivation of pathogens using metal-based coordination complexes, and methods and compositions for treating and preventing microbial and/or viral infections1 Sep 2026US 12,721,854 B2Theralase Technologies, Inc.
- Baculovirus expression vector4 Aug 2026US 12,697,381 B2Intervet Inc.
- Foot-and-mouth disease virus-like particle antigen, vaccine composition, preparation method, and use thereof28 Apr 2026US 12,611,452 B2Pulike Biological Engineering, Inc.
- Differential coating of microprojections and microneedles on arrays8 Oct 2026US 2026/0306611 A1Vaxxas Pty Limited
- Nucleic acid-lipid nanoparticle composition, and lyophilized preparation thereof, preparation method therefor and use thereof1 Oct 2026US 2026/0294829 A1Cansino Biologics Inc.
- Norovirus mrna vaccines10 Sep 2026US 2026/0263582 A1ModernaTX, Inc.
- Vaccine compositions and methods for control of foot and mouth disease10 Sep 2026US 2026/0263583 A1Indian Council of Agricultural Research
- Triple mrna vaccine for preventing feline rhinotracheitis, feline caliciviral disease, and feline panleukopenia, and preparation method thereof6 Aug 2026US 2026/0224690 A1Zhejiang University
Most cited
By later US patents
- Method for processing and preserving collagen-based tissues for transplantation610US 5,336,616 ALifeCell Corporation · 1994
- Antigenically active amino acid sequences190US 4,708,871 ACommonwealth Serum Laboratories Commission · 1987
- Method of cryopreserving a suspension of biological material150US 5,364,756 ALifeCell Corporation · 1994
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions90US 5,780,295 ALife Cell Corporation · 1998